News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
CVS Health (NYSE: CVS) is set to report its Q2 earnings this Wednesday, with market expectations for flat year-on-year revenue. The company had a strong Q1, beating revenue and EPS estimates. Analysts have largely reconfirmed their estimates, suggesting stability, and CVS stock has seen …
Sharemaestro market context Trend signal active 52 weeks +39.7%Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CVS Health (CVS), which belongs to the Zacks Medical Services industry. This drugstore chain and pharmacy benefits manager has seen …
Sharemaestro market context Trend signal active 52 weeks +39.7%CVS Health Corp. has won a False Claims Act lawsuit filed by whistleblower Ellsworth Associates LLP. The suit alleged that CVS and other entities engaged in an anticompetitive scheme to prevent Medicare Part D recipients from accessing less expensive generic drugs. A US District …
CVS Health Corp. has expanded its prescription services to include common pet medications at 9,000 of its pharmacies nationwide. Pet owners can now fill prescriptions for antibiotics, allergy treatments, flea and tick control, insulin, and pain relievers, with options for in-store pickup or delivery. …
CVS Health Corp (1CVS) reported strong Q1 2025 earnings, beating analyst expectations for both EPS and revenue. The company recorded an actual EPS of €1.95 against a consensus of €1.48, and actual revenue of €82.01 billion, surpassing the expected €81.20 billion. This represents a …
This article provides the "Price to sales forward" data for VSee Health, Inc. (BOATS:VSEEW). It presents a specific financial metric for the company, indicating its valuation based on future sales. The content primarily focuses on this single financial data point without further analysis or …
The article provides a revenue breakdown for VSee Health, Inc. (NASDAQ: VSEEW), highlighting that the United States is its largest revenue contributor. In the last year, the U.S. segment generated $14.62 million USD, an increase from $10.42 million USD the previous year. The data …
Kyivstar Group's stock has seen a 30.1% return over the past year, but its current pricing appears to be broadly in line with its fundamentals, neither significantly cheap nor expensive. The company trades at a premium on P/E ratio compared to its industry and …
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recent earnings expectations and fresh store openings have put CVS Health (CVS) in focus …
Sharemaestro market context Trend signal active 52 weeks +20.8%VSee Health has secured a $336,000 unsecured convertible promissory note from Labrys, which includes a $36,000 original issue discount and carries a 12% interest charge, maturing on June 30, 2027. The agreement allows for optional prepayment and a proceeds sweep mechanism for repayment. Conversion …
VSee Health has signed a non-binding letter of intent to acquire healthcare technology and operating assets valued at approximately $42 million. This acquisition will bring an integrated healthcare commerce platform with over $35 million in annual revenue and $7 million in EBITDA into VSee's …
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. CVS Health stock has returned 74.8% over the past year, yet its broader valuation checks lean expensive, so investors are weighing a strong share …
Sharemaestro market context Trend signal active 52 weeks +20.8%This article provides detailed stock information for Kyivstar Group Ltd. (KYIV), including its current price, recent financial performance, and a history of news and press releases. Key highlights include strong Q2 and Q1 2026 earnings, increased revenue and EBITDA outlooks, and strategic initiatives such …
Vanguard Capital Management has reported a 5.18% beneficial ownership stake in VSE Corp (VSEC), amounting to 1,454,475 shares, as per a Schedule 13G SEC filing. Vanguard maintains sole voting power over 212,285 shares and sole dispositive power over all 1,454,475 shares. This disclosure highlights …
Kyivstar Group reported strong financial results for the first half of 2026, with revenue rising 22.8% to $662 million and profit increasing 28.6% to $162 million, despite operating amid the war in Ukraine. The growth was driven by telecommunication and digital revenue, including contributions …
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …
Sharemaestro market context Trend signal active 52 weeks +39.7%Wall Street analysts forecast that CVS Health (CVS) will report quarterly earnings of $1.87 per share in its upcoming release, pointing to a year-over-year increase of 3.3%. It is anticipated that revenues will amount to $100.18 billion, exhibiting an increase of 1.3% compared to …
Sharemaestro market context Trend signal active 52 weeks +20.8%This article provides a financial overview of Kyivstar Group Ltd. (NASDAQ: KYIVW), focusing on its revenue breakdown. It highlights the company's financial data, including statements, statistics, dividends, earnings, and segment performance by source and country, all within the TradingView platform context.
Kyivstar Group Ltd., Ukraine's largest telecoms operator, has opened a new office in New York's Rockefeller Center. This move aims to strengthen investor relations, foster international partnerships, and present Ukraine's investment potential to the global community, following its historic Nasdaq listing in August 2025. …
Kyivstar Group reported a decline in Q2 earnings due to higher depreciation and amortization costs, despite a 5.6% increase in revenue to UAH 8.54 billion. The company also raised its 2026 revenue growth guidance to 7-9% from the previous 5-7%, while maintaining its capital …
Kyivstar Group is attracting attention after opening a New York office, formalizing its U.S. presence following its 2025 Nasdaq listing. Despite mixed short-term share price momentum, analysts believe the stock is undervalued, with a fair value estimated at $17.68 compared to its recent close …
Kyivstar Group Ltd. filed a Form 424B3 Prospectus Supplement No. 5 on July 31, 2026, to update its registration statement regarding the resale of common shares and common shares underlying warrants. The supplement incorporates information from the company's Annual Report on Form 20-F and …
VSE Corp (VSEC) currently holds an institutional shareholding score of 10.00, placing it at the top of the Aerospace & Defense industry. The institutional shareholding proportion has increased by 34.54% quarter-over-quarter to 112.87%. George Soros is the largest institutional shareholder, holding 166.93K shares, which …
Kyivstar ซึ่งเป็นส่วนหนึ่งของกลุ่มบริษัทโทรคมนาคม VEON ได้ประกาศเปิดสำนักงานแห่งใหม่ในนิวยอร์ก การย้ายครั้งนี้มีเป้าหมายเพื่อเสริมสร้างความสัมพันธ์กับนักลงทุนและภาคธุรกิจในสหรัฐอเมริกา และเป็นการตอกย้ำความมุ่งมั่นของ Kyivstar ที่จะรักษาการดำเนินงานในยูเครนต่อไป รวมถึงการแสวงหาโอกาสใหม่ ๆ ในการพัฒนาธุรกิจในระดับสากล
KYIV, Ukraine and NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- Kyivstar Group Ltd. (Nasdaq: KYIV, KYIVW) (“Kyivstar” or the “Group”), Ukraine’s leading digital operator, today reported financial and operating results for the second quarter and half-year ended June 30, 2026. On the back …
VSE Corp. (NASDAQ: VSEC), an Aerospace and Defense company, had approximately 1,616 employees worldwide as of March 2026, marking a 4.7% decline from 2023. The workforce is primarily concentrated in North America, with functional groups led by Finance and Operations. The company is actively …
Kyivstar Group Ltd. is set to report its second-quarter earnings, with investors focused on the sustainability of its digital transformation growth and the impact of geopolitical developments, particularly increased NATO support for Ukraine. Analysts anticipate earnings of $0.36 per share, and the company's stock …
This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Knorr-Bremse AG (KNRRY) achieved its highest quarterly operating EBIT margin in five and a half …
Sharemaestro market context Trend signal active 52 weeks +20.8%VSee Health Inc. (NASDAQ: VSEE) has signed a non-binding letter of intent to acquire a vertically integrated healthcare commerce platform for approximately $42 million. This acquisition is expected to add over $35 million in annualized revenue and about $7 million in EBITDA, significantly expanding …
The enterprise earned the program's top honor plus gold recognition in AI innovation, measurement excellence, employee engagement, and consumer-centric culture WOONSOCKET, R.I., July 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that it has been named Overall Winner and earned four gold …
VSee Health (NASDAQ: VSEE) has entered into a non-binding letter of intent to acquire healthcare technology and operating assets for approximately $42 million. This acquisition is projected to add over $35 million in unaudited annual revenue run rate and about $7 million in EBITDA. …
VSee Health Inc. announced it has entered into a non-binding letter of intent to acquire specific healthcare technology and operating assets. These assets operate an integrated healthcare commerce platform catering to the U.S. clinic-based wellness market, with current unaudited annual run rates exceeding $35 …
VSee Health, Inc. has signed a non-binding letter of intent to acquire certain healthcare technology and operating assets for $42 million. This acquisition is expected to add over $35 million in annualized revenue and approximately $7 million in EBITDA. The transaction aligns with VSee's …
Search by ticker symbol or company name and select a result to open its chart.